News
Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...
6d
Raw Story on MSNNew Trump threat poised to send medication prices soaringAt a cabinet meeting Tuesday, President Donald Trump floated the idea of imposing a 200% tariff rate on pharmaceuticals, ...
Prescription price controls and importing inferior medications will hurt both patients and America’s standards. We should ...
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
3d
Stocktwits on MSNFDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: ReportThe U.S. Food and Drug Administration may reportedly fast-track new drugs from pharmaceutical companies that “equalize” the ...
5d
Straight Arrow News on MSNTrump's ‘Big Beautiful Bill' revives incentives for orphan drugsPresident Trump's "Big Beautiful' Bill" includes a provision incentivizing the study of "orphan drugs" to treat rare diseases.
The U.S. has the highest drug prices in the world, with the average list price more than three times higher than Canada’s.
Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...
US President Donald Trump has confirmed a steep 50 percent tariff on copper imports and threatened up to 200 percent duties ...
8d
Vietnam Investment Review on MSNWhat lies ahead through US drug pricing shake upDuyen Ha Vo, senior partner, Vilaf Finished pharmaceutical products were initially excluded from US President Donald Trump’s reciprocal tariff regime announced in April. However, President Trump ...
Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.
The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results